ApprovalTrail

Approval · Notice of Compliance 34771 · 2025

IMVAMUNE: Notice of Compliance 34771

Issued January 30, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
34771
Date
January 30, 2025
Company
Bavarian Nordic AsHellerup, Denmark
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Product Monograph update

Products in this notice

BrandDINStatus today
IMVAMUNENot yet assigned—

Medicinal ingredients